Execs Could Go To Jail For False Info In FDA Submissions Under Senate Bill
This article was originally published in The Gray Sheet
Executive Summary
Device and drug company executives could face prison time if a submission to FDA turns out to be false or misleading, under a bill introduced in the Senate July 31